The measures focus on treatment processes and outcomes for asthma, chronic obstructive pulmonary disease and pneumonia. Three were new measures and 16 were maintenance measures. The measures are as follows:
Asthma
• 0036: Use of appropriate medications for people with asthma (NCQA)
• 0047: Asthma: Pharmacologic therapy for persistent asthma (AMA-PCPI)
• 1799: Medication management for people with asthma (MMA) (NCQA)
• 1800: Asthma medication ratio (AMR) (NCQA)
• 0548: Suboptimal asthma control (SAC) and absence of controller therapy (ACT) (Pharmacy Quality Alliance, Inc.)
• 0143: CAC-1: Relievers for inpatient asthma (Joint Commission) *reserve status
• 0144: CAC-2 Systemic corticosteroids for inpatient asthma (Joint Commission) *reserve status
COPD
• 0091: COPD: spirometry evaluation (AMA-PCPI)
• 0102: COPD: inhaled bronchodilator therapy (AMA-PCPI)
• 0577: Use of spirometry testing in the assessment and diagnosis of COPD (NCQA)
• 1825: COPD – management of poorly controlled COPD (ActiveHealth Management)
Pneumonia
• 0096: Empiric antibiotic for community-acquired bacterial pneumonia (AMA-PCPI)
• 0147: Initial antibiotic selection for community-acquired pneumonia (CAP) in immunocompetent patients (CMS)
• 0231: Pneumonia Mortality Rate (IQI #20) (AHRQ)
• 0468: Hospital 30-day, all-cause, risk-standardized mortality rate (RSMR) following pneumonia hospitalization (CMS)
Critical Care
• 0334: PICU Severity-adjusted length of stay (Virtual PICU Systems, LLC) *paired with 0335
• 0335: PICU Unplanned readmission rate (Virtual PICU Systems, LLC) *paired with 0334
• 0343: PICU Standardized Mortality Ratio (Virtual PICU Systems, LLC)
Imaging
• 0513: Thorax CT: Use of contrast material (CMS)
More Articles on NQF:
NQF Endorses Additional Surgical Measures
NQF Endorses Measurement Framework for Multiple Chronic Conditions
